{"name":"Wanpen Vongpatanasin","slug":"wanpen-vongpatanasin","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Dextrose infusion","genericName":"Dextrose infusion","slug":"dextrose-infusion","indication":"Other","status":"marketed"},{"name":"Human Recombinant Regular Insulin infusion","genericName":"Human Recombinant Regular Insulin infusion","slug":"human-recombinant-regular-insulin-infusion","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Dextrose infusion","genericName":"Dextrose infusion","slug":"dextrose-infusion","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Human Recombinant Regular Insulin infusion","genericName":"Human Recombinant Regular Insulin infusion","slug":"human-recombinant-regular-insulin-infusion","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOMXhVY01uTjZtX2FrZVNuOXlVTHRac0RaY0ZFYTJQMFVsX0lPc2ZmbVU5VmtRMVNTVVJURnB3LVo4cmljbFIzWnE4am9TVDlMNVlLc0hqYjJtSkoyLTF6ZFhIN0IxNFFmLXpVVGJDMGhXVXk1clI1OFBBV0xjN0FjZzM0VGtvZjFtUFVSUDFsLTZrRUw2emlJLTdwYVRFUVFydmltRk9acmxLaTNIMDg5YWUtSURyVVhPZWpEOXZvU3JGRWRaTmc?oc=5","date":"2026-01-27","type":"pipeline","source":"UT Southwestern Medical Center","summary":"News Highlights - January 27, 2026 - UT Southwestern Medical Center","headline":"News Highlights - January 27, 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFB0MmtHZFVrbTI4bjBvNnE4Mk03cTRfMWdYejV1MGIxNjR2bVRqM3phNnNqRDNJc3FOdWRNX1dQR0w5dnk0MDFuUDFQZGwzc0VwNWNMYUpUR1JORTlBVE04b3BVbU45MmN1NjF3NHMtamk5a0pJWVFqMA?oc=5","date":"2025-03-10","type":"pipeline","source":"ahajournals.org","summary":"The Journey of Resistant Hypertension: From the Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure to American Heart Association/American Colle","headline":"The Journey of Resistant Hypertension: From the Fifth Report of the Joint National Committee on Detection, Evaluation, a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1GNkVFQ3RENVJJTWtJZXJ1VElVNDNEUFJHbkFvTWZLLW9yZ3pPeDA5T1NYOU5lZVVnM0Y5NGNsbnNaa2NHT3hMZnhmampNYnhienZnOXRoMklyMFhwdnZoVXkwWU5PV3owVFdBLUY0UDBELV9mcUZtaQ?oc=5","date":"2021-05-03","type":"pipeline","source":"ahajournals.org","summary":"Are SGLT2 Inhibitors New Hypertension Drugs? | Circulation - ahajournals.org","headline":"Are SGLT2 Inhibitors New Hypertension Drugs? | Circulation","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}